Hitting the Sweet Spot in Diabetes Management: The Association of SGLT-2 Inhibitors and Euglycemic Diabetic Ketoacidosis

Florence Rochelle Gan, MD, FPCP, FPCEDM   The discovery of sodium-glucose cotransporter-2 inhibitors (SGLT2i) is a major turning point in